Skip to Main Content

Paper Details

Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
Journal of Hematology and Oncology
23
2021
8-Cl-ATP, 8-Cl-Ado, 8-chloro-adenosine, AML, AML blast cells, AML cell lines, AML cells, BCL-2, FAO, LSC, LSC-enriched blast cells, LSC-enriched population, LSCs, MV4, MV4-11-Luc AML cells, OXPHOS, VEN, acute myeloid leukemia, acute myeloid leukemia (AML) blast cells, acute myeloid leukemia blasts, amino acid, drug-resistant LSCs, fatty acid, gene set, leukemic, leukemic stem cells, mice, mouse, oxygen, patients, ribonucleoside, venetoclax
Author NameAffiliation
Steven T RosenHematology Malignancies Research Institute, Gehr Family Center for Leukemia Research, City of Hope Medical Center
  • 1 - 1

Datasets

Release 1.2